JPRN-UMIN000028421招募中未知
Efficacy and safety of new drugs for induction, autologous stem cell transplantation, consolidation and maintenance therapy in patients with newly diagnosed elderly symptomatic multiple myeloma: phase 2 study FBMTG EMM17 - FBMTG EMM17
FBMTG0 个研究点目标入组 49 人开始时间: 2017年10月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 49
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 66years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Non-secretory MM and plasma cell leukemia. 2) Patients HIV-positive 3) Severe hepatic dysfunction, severe renal failure, severe cardiac dysfunction, severe pulmonary dysfunction, uncontrolled diabetes, uncontrolled hypertension, and uncontrolled infection. 4) Patients with a history of active malignancy during the past 5 years. 5) Patients with psychiatric disorders such as schizophrenia etc. 6) Pregnant women, pre-menopausal women, and lactating women. 7) History of hypersensitivity to mannitol or boron. 8) Patient was suspected pneumonia(Interstitial pneumonia). Consult a respiratory specialist if necessary 9) Those who are considered as inappropriate to register by attending physicians.
研究者
相似试验
招募中
不适用
Efficacy and safety of new drugs for induction, autologous stem cell transplantation, consolidation and maintenance therapy in patients with newly diagnosed symptomatic multiple myeloma: a phase 2 studyMultiple myelomaJPRN-UMIN000024165JSCT133
已完成
2 期
Efficacy and safety of new drugs for induction, autologous stem cell transplantation, and consolidation therapy in elderiy patients with newly diagnosed symptomatic multiple myeloma.Multiple myelomaJPRN-UMIN000010166Fukuoka Blood and Marrow Transplantation Group50
已完成
不适用
Efficacy and safety of new drugs for induction, autologous stem cell transplantation, consolidation and maintenance therapy in patients with newly diagnosed symptomatic multiple myeloma: a phase2 studyMultiple myelomaJPRN-UMIN000007216Japan Study Group for Cell Therapy and Transplantation56
进行中（未招募）
2 期
ewly diagnosed elderly symptomatic multiple myeloma: phase 2 studyMultiple myelomaJPRN-jRCTs071180031Tanimoto Kazuki49
已完成
2 期
ew drugs for therapy in patients with newly diagnosed symptomatic multiple myeloma: a phase2 study -JSCT MM16Multiple myelomaJPRN-jRCTs071180019Miyamoto Toshihiro141